Gene · 8242
Papers1,955
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 1,955
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Genetic variants and phenotypic data curated for the CAGI6 intellectual disability panel challenge. | Hum Genet | 2025 | 40019509 | PubTator, text mining | PubMed |
| The genomic landscape of metastatic clear-cell renal cell carcinoma and its prognostic value: a comprehensive analysis of a large real-world clinico-genomic database. | ESMO Open | 2025 | 39965361 | PubTator, text mining | PubMed |
| The transcriptomic landscape of monosomy X (45,X) during early human fetal and placental development. | Commun Biol | 2025 | 39956831 | PubTator, text mining | PubMed |
| KDM5C and KDM5D mutations have different consequences in clear cell renal cell carcinoma cells. | Commun Biol | 2025 | 39955388 | PubTator, text mining | PubMed |
| A novel KDM5C mutation associated with intellectual disability: molecular mechanisms and clinical implications. | Ital J Pediatr | 2025 | 39948613 | PubTator, text mining | PubMed |
| A neoantigen vaccine generates antitumour immunity in renal cell carcinoma. | Nature | 2025 | 39910301 | PubTator, text mining | PubMed |
| A novel KDM5C variant corrects a previously erroneous diagnosis. | Eur J Med Genet | 2025 | 39900177 | PubTator, text mining | PubMed |
| The histone demethylase KDM5C enhances the sensitivity of acute myeloid leukemia cells to lenalidomide by stabilizing cereblon. | Cell Mol Biol Lett | 2025 | 39881283 | PubTator, text mining | PubMed |
| Clinical Features and Genetic Characteristics of XLID Patients With KDM5C Gene Mutations: Insights on Phenotype-Genotype Correlations From 175 Previous Cases and Identification of a Novel Variant. | Mol Genet Genomic Med | 2025 | 39835750 | PubTator, text mining | PubMed |
| Catalytic-independent functions of the Integrator-PP2A complex (INTAC) confer sensitivity to BET inhibition. | Nat Chem Biol | 2025 | 39809894 | PubTator, text mining | PubMed |
| Escape of Kdm6a from X Chromosome Is Detrimental to Ischemic Brains via IRF5 Signaling. | Transl Stroke Res | 2025 | 39752046 | PubTator, text mining | PubMed |
| Biomarker analyses from the phase III randomized CLEAR trial: lenvatinib plus pembrolizumab versus sunitinib in advanced renal cell carcinoma. | Ann Oncol | 2025 | 39672382 | PubTator, text mining | PubMed |
| Androgen Effects on Alcohol-induced Liver Fibrosis Are Controlled by a Notch-dependent Epigenetic Switch. | Cell Mol Gastroenterol Hepatol | 2025 | 39349250 | PubTator, text mining | PubMed |
| A Scoping Review of Population Diversity in the Common Genomic Aberrations of Clear Cell Renal Cell Carcinoma. | Oncology | 2025 | 39250899 | PubTator, text mining | PubMed |
| Targeting the transcription factor YY1 is synthetic lethal with loss of the histone demethylase KDM5C. | EMBO Rep | 2024 | 39433896 | PubTator, text mining | PubMed |
| Post-Translational Modifications of RNA-Modifying Proteins in Cellular Dynamics and Disease Progression. | Adv Sci (Weinh) | 2024 | 39377984 | PubTator, text mining | PubMed |
| Brief research report: WGCNA-driven identification of histone modification genes as potential biomarkers in AQP4-Associated optic neuritis. | Front Genet | 2024 | 39238786 | PubTator, text mining | PubMed |
| Compensation of gene dosage on the mammalian X. | Development | 2024 | 39140247 | PubTator, text mining | PubMed |
| Transcriptional programming mediated by the histone demethylase KDM5C regulates dendritic cell population heterogeneity and function. | Cell Rep | 2024 | 39052479 | PubTator, text mining | PubMed |
| Comparing the roles of sex chromosome-encoded protein homologs in gene regulation. | Genes Dev | 2024 | 39048311 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8242/papers?page=5